• HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
Thursday, October 2, 2025
BIOENGINEER.ORG
No Result
View All Result
  • Login
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
  • HOME
  • NEWS
  • EXPLORE
    • CAREER
      • Companies
      • Jobs
        • Lecturer
        • PhD Studentship
        • Postdoc
        • Research Assistant
    • EVENTS
    • iGEM
      • News
      • Team
    • PHOTOS
    • VIDEO
    • WIKI
  • BLOG
  • COMMUNITY
    • FACEBOOK
    • INSTAGRAM
    • TWITTER
No Result
View All Result
Bioengineer.org
No Result
View All Result
Home NEWS Science News

Newly prescribed sleeping pills increase risk of hip fracture

Bioengineer by Bioengineer
April 26, 2017
in Science News
Reading Time: 3 mins read
0
Share on FacebookShare on TwitterShare on LinkedinShare on RedditShare on Telegram

Older people newly prescribed sleeping pills like benzodiazepines and 'Z-drugs' have over double the odds of a hip fracture in the first two weeks compared with non-users, according to a new study by researchers at Cardiff University and King's College London.

Dr Ben Carter, Cardiff University's School of Medicine and the Institute of Psychiatry, Psychology and Neuroscience, King's College London, explains: "While 'Z-drugs are fast becoming the doctor's hypnotic prescription of choice, there is no evidence that they are a safer alternative to benzodiazepines in relation to hip fracture risk.

"Our study shows that both appear to significantly increase the risk of hip fracture when newly prescribed by doctors."

The study of people aged over 65 found that new users of these hypnotic medicines experienced nearly two and a half times the fracture rate, when compared with older people not taking hypnotics. An estimated 53% increase in fracture risk was identified in medium-term users (15 to 30 days), as well as a 20% increased risk of hip fracture in long-term users (greater than 30 days).

Dr Carter added: "Careful consideration of the immediate increased risk of hip fracture should inform the clinical decision-making process. Clinically effective measures like strength training to improve frailty, removal of hazards at home, visual correction and a medication review are also needed to mitigate the risk of hip fractures, particularly in the first few days of use."

The research supports previous studies linking use of hypnotics by older people with an increased risk of accidents, dependence, cognitive decline and hip fracture. The drugs are also thought to cause drowsiness, delayed reaction times and impaired balance.

'Benzodiazepines, Z-drugs and the risk of hip fracture: A Systematic Review and Meta-Analysis' is published today in PLOS ONE.

###

Notes to editors

This was a systematic review and meta-analysis of observational studies which means that although all of the evidence was gathered together, we cannot claim that newly prescribed sleeping pills like benzodiazepines and 'Z-drugs' cause hip fractures because other unmeasured factors could be involved. An experimental trial is needed to show cause and effect.

For further information contact:

Jonathan Rees
Communications & Marketing
Cardiff University
Tel: 02920 870298
Email: [email protected]

About Cardiff University

Cardiff University is recognised in independent government assessments as one of Britain's leading teaching and research universities and is a member of the Russell Group of the UK's most research intensive universities. The 2014 Research Excellence Framework ranked the University 5th in the UK for research excellence. Among its academic staff are two Nobel Laureates, including the winner of the 2007 Nobel Prize for Medicine, Professor Sir Martin Evans. Founded by Royal Charter in 1883, today the University combines impressive modern facilities and a dynamic approach to teaching and research. The University's breadth of expertise encompasses: the College of Arts, Humanities and Social Sciences; the College of Biomedical and Life Sciences; and the College of Physical Sciences and Engineering, along with a longstanding commitment to lifelong learning. Cardiff's flagship Research Institutes are offering radical new approaches to pressing global problems. http://www.cardiff.ac.uk

Media Contact

Jonathan Rees
[email protected]
44-029-208-70298
@cardiffuni

http://www.cardiff.ac.uk

############

Story Source: Materials provided by Scienmag

Share12Tweet7Share2ShareShareShare1

Related Posts

blank

Exploring RNA-Protein Interactions: A Pathway to Innovative Cancer and Brain Disease Therapies

October 2, 2025

Clinical Trial Explores Internal Radiation Therapy for Kidney Cancer Treatment

October 2, 2025

Embracing Uncertainty: A New Approach for Engineers in Designing Complex Systems

October 2, 2025

Advancing Efficient Room-Temperature Fluorine Recovery from Fluoropolymers

October 2, 2025
Please login to join discussion

POPULAR NEWS

  • New Study Reveals the Science Behind Exercise and Weight Loss

    New Study Reveals the Science Behind Exercise and Weight Loss

    91 shares
    Share 36 Tweet 23
  • New Study Indicates Children’s Risk of Long COVID Could Double Following a Second Infection – The Lancet Infectious Diseases

    79 shares
    Share 32 Tweet 20
  • Physicists Develop Visible Time Crystal for the First Time

    74 shares
    Share 30 Tweet 19
  • How Donor Human Milk Storage Impacts Gut Health in Preemies

    65 shares
    Share 26 Tweet 16

About

We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.

Follow us

Recent News

Exploring RNA-Protein Interactions: A Pathway to Innovative Cancer and Brain Disease Therapies

Clinical Trial Explores Internal Radiation Therapy for Kidney Cancer Treatment

Embracing Uncertainty: A New Approach for Engineers in Designing Complex Systems

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 60 other subscribers
  • Contact Us

Bioengineer.org © Copyright 2023 All Rights Reserved.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Homepages
    • Home Page 1
    • Home Page 2
  • News
  • National
  • Business
  • Health
  • Lifestyle
  • Science

Bioengineer.org © Copyright 2023 All Rights Reserved.